As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Reviews, Research Highlights and Commentaries
Read the latest papers on pathogens, disease and diagnostics across BMC flagship journals.
Evaluation of the potential incidence of COVID-19 and effectiveness of containment measures in Spain: a data-driven approach
Alberto Aleta and Yamir Moreno
Published in BMC Medicine 27 May 2020
MARPLE, a point-of-care, strain-level disease diagnostics and surveillance tool for complex fungal pathogens
Guru Radhakrishnan et al.
Published in BMC Biology 13 August 2019
Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential
Kara A. Moser et al.
Published in Genome Medicine 08 January 2020
SEPATH: benchmarking the search for pathogens in human tissue whole genome sequence data leads to template pipelines
Abraham Gihawi et al.
Published in Genome Biology 22 October 2019
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
A decade of Genome Medicine
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
From the blog
21 September 2020
18 September 2020
18 September 2020
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
C19 Rapid Review Initiative
Genome Medicine has joined the C19 Rapid Review Initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.